## ROP: Roper Technologies, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 1.9% below STRENGTH zone (4.0-10.0%); PEG 1.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($435.03)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Roper Technologies (ROP): Has the Recent Share Price Slide Opened a Valuation Opportunity?**
- Source: Simply Wall Street | 20251217T110821 | Somewhat-Bullish | Relevance: 100%
- Roper Technologies (ROP) has seen its shares decline by about 14% year-to-date despite steady growth in revenue and net income. This slide suggests investors are re-evaluating its growth profile, leading to a potential undervaluation with a narrative fair value of $573.56 against its current price of $443.78, according to Simply Wall Street's analysis. The article explores whether this presents a buying opportunity, considering ongoing capital deployment into high-margin software leaders and potential risks from M&A integration and AI intensification.

**2. Roper Technologies (NASDAQ:ROP) Price Target Lowered to $507.00 at The Goldman Sachs Group**
- Source: MarketBeat | 20251217T180833 | Neutral | Relevance: 100%
- The Goldman Sachs Group has reduced its price target for Roper Technologies (NASDAQ:ROP) to $507.00 from $572.00, while maintaining a "neutral" rating. Despite this, the consensus among analysts remains a "Moderate Buy" with a mean target of $572.14. Recently, company insiders, including CEO Laurence Neil Hunn and Director Amy Woods Brinkley, purchased shares, demonstrating confidence in the company.

**3. Goldman Sachs Sticks to Its Hold Rating for Roper Technologies (ROP)**
- Source: The Globe and Mail | 20251217T170831 | Neutral | Relevance: 100%
- Goldman Sachs has reiterated its "Hold" rating for Roper Technologies (ROP) and set a price target of $507.00. The general Street consensus suggests a "Moderate Buy" for ROP with an average price target of $567.92. Despite positive insider sentiment indicated by increased insider buying, a recent notable sale by EVP & CFO Jason Conley of 6,000 shares for over $2.6 million was reported.

**4. Union Bancaire Privee UBP SA Lowers Stock Holdings in Roper Technologies, Inc. $ROP**
- Source: MarketBeat | 20251217T141059 | Neutral | Relevance: 100%
- Union Bancaire Privee UBP SA has reduced its stake in Roper Technologies (NASDAQ:ROP) by 19.8%, now holding 94,059 shares valued at approximately $43.88 million. Despite this reduction, analysts maintain a "Moderate Buy" rating for Roper with an average target price of $577.15. The company recently exceeded Q3 EPS estimates, offered robust guidance for Q4 and FY2025, increased its quarterly dividend, and reported mixed insider transactions.

**5. Roper Technologies (ROP): Has the Recent Share Price Slide Opened a Valuation Opportunity?**
- Source: Simply Wall Street | 20251217T105136 | Bullish | Relevance: 100%
- Roper Technologies (ROP) shares have declined by approximately 14% year-to-date despite consistent revenue and net income growth, leading analysts to label the stock as 22.6% undervalued with a fair value of $573.56. The valuation suggests significant upside potential if projected cash flows materialize, driven by disciplined capital deployment into high-growth, high-margin software leaders. However, this upside is contingent on successful M&A integration and Roper's ability to maintain software differentiation amidst increasing AI competition.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Goldman Sachs | $507 | $572 | -11% |
| 2025-12-04 | Barclays | $475 | $506 | -6% |
| 2025-11-20 | Piper Sandler | $600 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Goldman Sachs | main | Neutral |
| 2025-12-04 | Barclays | main | Underweight |
| 2025-11-20 | Piper Sandler | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($2.47M) |
| Sells | 2 ($0.77M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+1.8%)
- Blackrock Inc.: 8.6% (-2.1%)
- State Street Corpora: 4.7% (+0.9%)
- Morgan Stanley: 3.7% (+6.8%)
- JPMORGAN CHASE & CO: 3.0% (+225.1%)

### Key Risks

1. Long-term trend broken: trading 14.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +2.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.96 elevated, pricing in significant growth expectations. Forward P/E 20.8x stretched relative to 8% growth. Quality metrics strong (margin 20%). Analyst sentiment negative (2 target cuts vs 0 raises). Insider buying signal ($2.5M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $48.5B |
| Beta | 0.94 |
| 52W Range | $435.42 - $595.17 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.96 |
| Forward P/E | 20.8 |
| Current P/E | 22.6 |
| YoY Growth | 8.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.1% to 1.9% (+2.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.1pp (needs >4.0% for momentum thesis). MRS_5 at 0.8% confirms short-term momentum alignment. Below SMA200 (0.85x), long-term trend not supportive. MACD histogram positive (1.99), confirming momentum. RSI neutral at 51. Elevated volume (2.0x 20MA), institutional activity likely. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.94% (CS: 59) | Neutral |
| RSI_14 | 51.2 | Neutral |
| MACD Histogram | 1.99 | Bullish |
| vs SMA20 | 1.012x | Above |
| vs SMA50 | 0.979x | Below |
| vs SMA200 | 0.853x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $450.51
- **Stop Loss:** $435.03 (3.4% risk)
- **Target:** $465.99 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 61
- **Position Value:** $27,481.11
- **Portfolio %:** 27.48%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-01-29 (Est: $5.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.11 | $5.14 | +0.6% |
| 2025Q2 | $4.83 | $4.87 | +0.8% |
| 2025Q1 | $4.74 | $4.78 | +0.8% |
| 2024Q4 | $4.73 | $4.81 | +1.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*